Ann Brinkmalm

5.4k citations

95 papers · 3.6k indexed · h-index 35

Impact in

Physiology top 0.5%
- Alzheimer's disease research and treatments
Biological Psychiatry top 2%

Papers in

Biological Psychiatry 7
Physiology 66
- Alzheimer's disease research and treatments 63

Co-authors: Kaj Blennow Henrik Zetterberg Gunnar Brinkmalm Erik Portelius Annika Öhrfelt Oskar Hansson Pia Davidsson Carol L. Nilsson
Journals: Alzheimer s & Dementia (13 papers)Alzheimer s Research & Therapy (7 papers)Journal of Proteome Research (4 papers)Rapid Communications in Mass Spectrometry (3 papers)Neurology (3 papers)
Partner nations: Sweden United Kingdom United States

In The Last Decade

Ann Brinkmalm

90 papers receiving 3.5k citations

Peers

Countries citing papers authored by Ann Brinkmalm

Since Specialization

Citations

This map shows the geographic impact of Ann Brinkmalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Brinkmalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Brinkmalm more than expected).

Fields of papers citing papers by Ann Brinkmalm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Brinkmalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Brinkmalm. The network helps show where Ann Brinkmalm may publish in the future.

Co-authors

The 25 scholars most cited alongside Ann Brinkmalm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann Brinkmalm Line = papers co-authored together Ann Brinkmalm links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes Annals of Clinical and Translational Neurology ·Hanwen Zhang, Daniel Kargilis, Thomas F. Tropea, John Robinson, Merna Maraie, 征雄三村, Ann Brinkmalm, Simon Sjödin, Hans Conrad Fischer, Marc Carceles‐Cordon, EunRan Suh, Sanika Sawant, Kaj Blennow, Daniel Weintraub, Edward B. Lee, Henrik Zetterberg, Alice Chen‐Plotkin	2025	1
2	Synaptosomal‐Associated Protein 25 kDA (SNAP‐25) Levels in Cerebrospinal Fluid: Implications for Alzheimer's Disease Diagnosis and Monitoring Synapse ·S Hodo, Mikko Lauronen, Christian Sandøe Musaeus, Peter Høgh, Nicholas J. Ashton, Ann Brinkmalm, Johanna Nilsson, Avril Bremnor, Henrik Zetterberg, Kaj Blennow, Steen Gregers Hasselbalch, Anne B. Walls, Anja Hviid Simonsen	2025	1
3	Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study Translational Psychiatry ·shouyong wang, Bernhard Schimmele, Göran Hagman, Ingemar Kåreholt, Mahdi Mojed Gharamaleki, Ann Brinkmalm, Henrik Zetterberg, Kaj Blennow, Alina Solomon, Miia Kivipelto, Shireen Sindi, Anna Matton	2024	5
4	Endo‐lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Anders Toft, Simon Sjödin, Anja Hviid Simonsen, Patrick Ejlerskov, 장화순, Christian Sandøe Musaeus, Yuzhuo Chang, Troels T. Nielsen, Ann Brinkmalm, Kaj Blennow, Henrik Zetterberg, Jørgen E. Nielsen	2023	2
5	Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer’s Disease Journal of Alzheimer s Disease ·E. van den Berg, Johanna Nilsson, Iris Kersten, Gunnar Brinkmalm, Anna M. de Kort, Catharina J.M. Klijn, Floris H.B.M. Schreuder, Lieke Jäkel, Johan Gobom, Erik Portelius, Henrik Zetterberg, Ann Brinkmalm, Kaj Blennow, H. Bea Kuiperij, Marcel M. Verbeek	2023	4
6	Reproductive span as a modifier of the association between AD biomarkers and cognitive decline in cognitively unimpaired women Alzheimer s & Dementia ·Marta Milà‐Alomà, Avin Adolf, Anna Brugulat‐Serrat, Gonzalo Sánchez‐Benavides, Afriadi Muflikhul Athfa, Ann Brinkmalm, Hlin Kvartsberg, Mahnaz Shekari, Eider M. Arenaza‐Urquijo, Sherezade Fuentes‐Julián, Carme Deulofeu, Oriol Grau‐Rivera, Gwendlyn Kollmorgen, Margherita Carboni, Maria Teresa Ferretti, Juan Domingo Gispert, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Marc Suárez‐Calvet	2023	1
7	Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry EBioMedicine ·Elena Camporesi, Johanna Nilsson, Agathe Vrillon, Emmanuel Cognat, Claire Hourrègue, Henrik Zetterberg, Kaj Blennow, Bruno Becker, Ann Brinkmalm, Claire Paquet, Gunnar Brinkmalm	2022	5
8	Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease Alzheimer s Research & Therapy ·Johanna Nilsson, Nicholas J. Ashton, Andréa Lessa Benedet, Laia Montoliu‐Gaya, Johan Gobom, Tharick A. Pascoal, Mira Chamoun, Erik Portelius, Andreas Jeromin, A Waise, Henrik Zetterberg, Pedro Rosa‐Neto, Ann Brinkmalm, Kaj Blennow	2022	22
9	CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB Movement Disorders ·Stefanie Lerche, Simon Sjödin, Ann Brinkmalm, Kaj Blennow, Isabel Wurster, Benjamin Röeben, Milan Zimmermann, Ann‐Kathrin Hauser, Inga Liepelt‐Scarfone, Katharina Waniek, Ingolf Lachmann, Thomas Gasser, Henrik Zetterberg, Kathrin Brockmann	2021	16
10	CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects IBRO Reports ·Hepni Putra, Carl M. Sellgren, Helena Fatouros‐Bergman, Fredrik Piehl, Kaj Blennow, Henrik Zetterberg, Ann Brinkmalm, Alexander Santillo, 良次西條, Simon Červenka, Göran Engberg, Sophie Erhardt	2020	6
11	Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease Brain ·Joana B. Pereira, Shorena Janelidze, Rik Ossenkoppele, Hlin Kvartsberg, Ann Brinkmalm, Niklas Mattsson, Erik Stomrud, Ruben Smith, Henrik Zetterberg, Kaj Blennow, Oskar Hansson	2020	142
12	Detection of α-Synuclein in Biological Samples Using Mass Spectrometry Methods in molecular biology ·Ann Brinkmalm, Annika Öhrfelt, Payel Bhattacharjee, Henrik Zetterberg	2019	5
13	Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease Alzheimer s Research & Therapy ·Simon Sjödin, Gunnar Brinkmalm, Annika Öhrfelt, Lucilla Parnetti, Silvia Paciotti, Oskar Hansson, John Hardy, Kaj Blennow, Henrik Zetterberg, Ann Brinkmalm	2019	64
14	CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia Alzheimer s Research & Therapy ·雄志地引, Ann Brinkmalm, Martha Foiani, Ione Woollacott, Carolin Heller, Amanda Heslegrave, Ashvini Keshavan, Nick C. Fox, Jonathan M. Schott, Jason D. Warren, Kaj Blennow, Henrik Zetterberg, Jonathan D. Rohrer	2019	42
15	Identification of Novel APP/Aβ Isoforms in Human Cerebrospinal Fluid Neurodegenerative Diseases ·Erik Portelius, Gunnar Brinkmalm, Salas Soto, Henrik Zetterberg, Ann Brinkmalm, Kaj Blennow	2009	61
16	A novel pathway for amyloid precursor protein processing Neurobiology of Aging ·Erik Portelius, Eric A. Price, Gunnar Brinkmalm, 星航, Maria Olsson, Rita Persson, Ann Brinkmalm, Henrik Zetterberg, Adam J. Simon, Kaj Blennow	2009	135
17	Evaluation of sample fractionation using micro‐scale liquid‐phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment Rapid Communications in Mass Spectrometry ·Annika Thorsell, Erik Portelius, Kaj Blennow, Ann Brinkmalm	2007	68
18	Proteome analysis of conditioned medium from cultured adult hippocampal progenitors Rapid Communications in Mass Spectrometry ·Barkha Singh, Peter S. Eriksson, Anders I. Persson, Francis Samuel Okosun, Pia Davidsson, Rolf Ekman, Ann Brinkmalm	2003	27
19	Elevated Levels of alpha-2-Heremans-Schmid Glycoprotein in CSF of Patients with Low-Grade Gliomas Tumor Biology ·Dan Ribom, Ann Brinkmalm, Anja Smits, Pia Davidsson	2003	19
20	Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients Neuroreport ·Pia Davidsson, Ann Brinkmalm, Carol L. Nilsson, A J Spak, Linda Paulson, Niels Andreasen, Magnus Gren, Kaj Blennow	2002	175

About Ann Brinkmalm

Ann Brinkmalm is a scholar working on Biological Psychiatry, Physiology, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Neurology, having authored 95 papers that have together received 3.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (63 papers), Neuroscience and Neuropharmacology Research (22 papers), Parkinson's Disease Mechanisms and Treatments (14 papers), Advanced Proteomics Techniques and Applications (14 papers), Dementia and Cognitive Impairment Research (13 papers), Metabolomics and Mass Spectrometry Studies (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and S100 Proteins and Annexins (7 papers). The work is most often cited by research in Physiology (2.1k citations), Biological Psychiatry (150 citations), Neurology (445 citations), Psychiatry and Mental health (706 citations) and Neurology (563 citations). Ann Brinkmalm has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Kaj Blennow, Henrik Zetterberg, Gunnar Brinkmalm, Erik Portelius, Annika Öhrfelt, Oskar Hansson, Pia Davidsson, Carol L. Nilsson, Ulf Andréasson and Niels Andreasen. Their work appears in journals such as Alzheimer s & Dementia, Alzheimer s Research & Therapy, Journal of Proteome Research, Rapid Communications in Mass Spectrometry and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact